Maybe I am being naive, but I think that Cytoden is better off without money from OWS. I don't want Cytodyn to be beholden to the federal government, and then in turn be hamstrung on Leronlimab pricing and distribution. We can get plenty of funds from corporate partnerships and charitable grants.